Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384818069> ?p ?o ?g. }
- W4384818069 abstract "Abstract We have previously shown that intradermal injection of high-molecular-weight hyaluronan (500-1200 kDa) produces localized antihyperalgesia in preclinical models of inflammatory and neuropathic pain. In the present experiments, we studied the therapeutic effect of topical hyaluronan, when combined with each of 3 transdermal drug delivery enhancers (dimethyl sulfoxide [DMSO], protamine or terpene), in preclinical models of inflammatory and neuropathic pain. Topical application of 500 to 1200 kDa hyaluronan (the molecular weight range used in our previous studies employing intradermal administration), dissolved in 75% DMSO in saline, markedly reduced prostaglandin E 2 (PGE 2 ) hyperalgesia, in male and female rats. Although topical 500- to 1200-kDa hyaluronan in DMSO vehicle dose dependently, also markedly, attenuated oxaliplatin chemotherapy–and paclitaxel chemotherapy–induced painful peripheral neuropathy (CIPN) in male rats, it lacked efficacy in female rats. However, following ovariectomy or intrathecal administration of an oligodeoxynucleotide antisense to G-protein–coupled estrogen receptor (GPR30) mRNA, CIPN in female rats was now attenuated by topical hyaluronan. Although topical coadministration of 150 to 300, 300 to 500, or 1500 to 1750 kDa hyaluronan with DMSO also attenuated CIPN, a slightly lower-molecular-weight hyaluronan (70-120 kDa) did not. The topical administration of a combination of hyaluronan with 2 other transdermal drug delivery enhancers, protamine and terpene, also attenuated CIPN hyperalgesia, an effect that was more prolonged than with DMSO vehicle. Repeated administration of topical hyaluronan prolonged the duration of antihyperalgesia. Our results support the use of topical hyaluronan, combined with chemically diverse nontoxic skin penetration enhancers, to induce marked antihyperalgesia in preclinical models of inflammatory and neuropathic pain." @default.
- W4384818069 created "2023-07-21" @default.
- W4384818069 creator A5018039172 @default.
- W4384818069 creator A5020176719 @default.
- W4384818069 creator A5037181353 @default.
- W4384818069 creator A5049476931 @default.
- W4384818069 date "2023-07-18" @default.
- W4384818069 modified "2023-09-24" @default.
- W4384818069 title "Topical coapplication of hyaluronan with transdermal drug delivery enhancers attenuates inflammatory and neuropathic pain" @default.
- W4384818069 cites W1582833462 @default.
- W4384818069 cites W1794575150 @default.
- W4384818069 cites W1950229121 @default.
- W4384818069 cites W1968495333 @default.
- W4384818069 cites W1976237200 @default.
- W4384818069 cites W1982059504 @default.
- W4384818069 cites W1983420263 @default.
- W4384818069 cites W1983587864 @default.
- W4384818069 cites W1987329859 @default.
- W4384818069 cites W1987527812 @default.
- W4384818069 cites W1990512833 @default.
- W4384818069 cites W1992756380 @default.
- W4384818069 cites W2003380614 @default.
- W4384818069 cites W2011033166 @default.
- W4384818069 cites W2017225673 @default.
- W4384818069 cites W2023183853 @default.
- W4384818069 cites W2027223564 @default.
- W4384818069 cites W2034664046 @default.
- W4384818069 cites W2035685439 @default.
- W4384818069 cites W2042981938 @default.
- W4384818069 cites W2043323520 @default.
- W4384818069 cites W2043812087 @default.
- W4384818069 cites W2045245671 @default.
- W4384818069 cites W2045282997 @default.
- W4384818069 cites W2049213018 @default.
- W4384818069 cites W2049592802 @default.
- W4384818069 cites W2050087641 @default.
- W4384818069 cites W2069765473 @default.
- W4384818069 cites W2070609275 @default.
- W4384818069 cites W2072942836 @default.
- W4384818069 cites W2073197172 @default.
- W4384818069 cites W2074311922 @default.
- W4384818069 cites W2077179584 @default.
- W4384818069 cites W2090851538 @default.
- W4384818069 cites W2094164955 @default.
- W4384818069 cites W2101934635 @default.
- W4384818069 cites W2108047618 @default.
- W4384818069 cites W2128085440 @default.
- W4384818069 cites W2142238897 @default.
- W4384818069 cites W2154310434 @default.
- W4384818069 cites W2156409369 @default.
- W4384818069 cites W2157344438 @default.
- W4384818069 cites W2164648537 @default.
- W4384818069 cites W2309663242 @default.
- W4384818069 cites W2314946663 @default.
- W4384818069 cites W2321569724 @default.
- W4384818069 cites W2340703676 @default.
- W4384818069 cites W2345610352 @default.
- W4384818069 cites W2520612158 @default.
- W4384818069 cites W2541757731 @default.
- W4384818069 cites W2549851450 @default.
- W4384818069 cites W2559840370 @default.
- W4384818069 cites W2566463473 @default.
- W4384818069 cites W2574631460 @default.
- W4384818069 cites W2581438826 @default.
- W4384818069 cites W2591905283 @default.
- W4384818069 cites W2595008877 @default.
- W4384818069 cites W2770495036 @default.
- W4384818069 cites W2791960492 @default.
- W4384818069 cites W2805580735 @default.
- W4384818069 cites W2898297972 @default.
- W4384818069 cites W2913224919 @default.
- W4384818069 cites W2923697933 @default.
- W4384818069 cites W2936355305 @default.
- W4384818069 cites W2942849113 @default.
- W4384818069 cites W2950898002 @default.
- W4384818069 cites W2951071083 @default.
- W4384818069 cites W3042430402 @default.
- W4384818069 cites W3093154503 @default.
- W4384818069 cites W3141040296 @default.
- W4384818069 cites W3153854471 @default.
- W4384818069 cites W3159871226 @default.
- W4384818069 cites W3195579541 @default.
- W4384818069 cites W4200319273 @default.
- W4384818069 cites W4240821889 @default.
- W4384818069 cites W4253779214 @default.
- W4384818069 doi "https://doi.org/10.1097/j.pain.0000000000002993" @default.
- W4384818069 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37467181" @default.
- W4384818069 hasPublicationYear "2023" @default.
- W4384818069 type Work @default.
- W4384818069 citedByCount "1" @default.
- W4384818069 countsByYear W43848180692023 @default.
- W4384818069 crossrefType "journal-article" @default.
- W4384818069 hasAuthorship W4384818069A5018039172 @default.
- W4384818069 hasAuthorship W4384818069A5020176719 @default.
- W4384818069 hasAuthorship W4384818069A5037181353 @default.
- W4384818069 hasAuthorship W4384818069A5049476931 @default.
- W4384818069 hasConcept C126322002 @default.
- W4384818069 hasConcept C15490471 @default.
- W4384818069 hasConcept C170493617 @default.
- W4384818069 hasConcept C205679159 @default.